ReviewIndian dermatology online journal
Psychological Morbidity in Chronic Dermatological Disorders: A Review.
Review in Indian dermatology online journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Well-being differences and changes in people with somatic and psychiatric disorders or multimorbidities: modelling COVID-19 as a global natural experiment of stress vulnerability.BMJ mental health · 2026Article
- Impact of facial telangiectasias and anemia on quality of life in patients with hereditary hemorrhagic telangiectasia: a cross-sectional study using FACE-Q.Journal of patient-reported outcomes · 2026Article
- Psychiatric Comorbidity in Hidradenitis Suppurativa-A Large-Scale Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Gut microbiota dysbiosis at the interface of neuropsychiatric disorders and their dermatological comorbidities.Gut microbes · 2025Review
- Review
- The Psychosocial Toll of Dyspigmentation.The Journal of clinical and aesthetic dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin diseases not only manifest physically but also significantly impact mental and emotional well-being due to the close biological connection between the skin and brain. Psychodermatology, a field that bridges dermatology and psychiatry, addresses the psychological aspects of dermatological disorders, which can profoundly affect quality of life. This review explores the psychological morbidity associated with common dermatological conditions, including acne vulgaris, alopecia areata, atopic dermatitis, hidradenitis suppurativa, leprosy, melasma, psoriasis, urticaria, and vitiligo. A comprehensive literature search was performed and studies assessing quality of life in common chronic dermatological disorders were analyzed. Patients with chronic skin conditions often experience anxiety, depression, social withdrawal, and stigmatization, which can impair their personal and professional lives. Psychometric tools like the Dermatology Life Quality Index (DLQI) and Patient Health Questionnaire-9 (PHQ-9) are essential for assessing the impact on quality of life and identifying psychiatric comorbidities. Despite the recognized link between dermatological conditions and mental health, these aspects often receive insufficient attention in clinical practice. This review highlights the need for a multidisciplinary approach that integrates psychological support with dermatological treatment. Effective management strategies, including cognitive behavioral therapy, psychotropic medications, and habit reversal therapy, are discussed as crucial components of patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.